ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      85.02
      0.28%
      Bitcoin
      65,134.21
      -0.01%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Atara Biotherapeutics Inc (ATRA)

      7. Atara Biotherapeutics Inc (ATRA) News

      ATRA

      Atara Biotherapeutics (ATRA)

      Atara Biotherapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATRA
      DateTimeSourceHeadlineSymbolCompany
      05/05/20224:19PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATRAAtara Biotherapeutics Inc
      05/05/20224:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRAAtara Biotherapeutics Inc
      05/05/20224:01PMBusiness WireAtara Biotherapeutics Announces First Quarter 2022 Financial Results and Operational ProgressNASDAQ:ATRAAtara Biotherapeutics Inc
      04/29/20224:01PMBusiness WireAtara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
      04/28/20224:01PMBusiness WireAtara Biotherapeutics to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022NASDAQ:ATRAAtara Biotherapeutics Inc
      04/27/20224:41PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ATRAAtara Biotherapeutics Inc
      04/22/20224:01PMBusiness WireAtara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
      04/08/20224:01PMBusiness WireAtara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
      04/05/20224:01PMBusiness WireAtara Biotherapeutics Names Biopharmaceutical Executive Charlene Banard as Chief Technical OfficerNASDAQ:ATRAAtara Biotherapeutics Inc
      04/04/20226:10PMTipRanksMizuho Securities Thinks Atara Biotherapeutics’ Stock is Going to RecoverNASDAQ:ATRAAtara Biotherapeutics Inc
      04/04/20224:01PMBusiness WireAtara Biotherapeutics Announces the Completion of the Acquisition of Its Cell Therapy Manufacturing Facility & Commencement of Long-Term Strategic Partnership with FujifilmNASDAQ:ATRAAtara Biotherapeutics Inc
      03/22/20228:35PMTipRanksMizuho Securities Thinks Atara Biotherapeutics’ Stock is Going to RecoverNASDAQ:ATRAAtara Biotherapeutics Inc
      03/15/20224:01PMBusiness WireAtara Biotherapeutics to Host EBV and MS DayNASDAQ:ATRAAtara Biotherapeutics Inc
      03/11/20225:05PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ATRAAtara Biotherapeutics Inc
      03/04/20224:01PMBusiness WireAtara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
      03/02/20228:00AMBusiness WireAtara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Cowen 42nd Annual Virtual Healthcare ConferenceNASDAQ:ATRAAtara Biotherapeutics Inc
      02/28/20226:01PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ATRAAtara Biotherapeutics Inc
      02/28/20224:05PMBusiness WireAtara Biotherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Operational ProgressNASDAQ:ATRAAtara Biotherapeutics Inc
      02/18/20228:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRAAtara Biotherapeutics Inc
      02/18/20228:00AMBusiness WireAtara Biotherapeutics Provides Update on ATA2271 Autologous CAR T TrialNASDAQ:ATRAAtara Biotherapeutics Inc
      02/17/20224:01PMBusiness WireAtara Biotherapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022NASDAQ:ATRAAtara Biotherapeutics Inc
      02/14/20226:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      02/14/20226:31PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ATRAAtara Biotherapeutics Inc
      02/14/20225:02PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ATRAAtara Biotherapeutics Inc
      02/09/20223:32PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ATRAAtara Biotherapeutics Inc
      02/09/20229:10AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ATRAAtara Biotherapeutics Inc
      02/07/20224:01PMBusiness WireAtara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
      02/03/20224:47PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ATRAAtara Biotherapeutics Inc
      01/26/20225:44PMDow Jones NewsFujifilm Subsidiary to Acquire Atara Bio's Cell Therapy Manufacturing FacilityNASDAQ:ATRAAtara Biotherapeutics Inc
      01/26/20225:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRAAtara Biotherapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ATRA